title: Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
abstract: Hypoxia-inducible factor (HIF) plays an important role in cell survival by regulating iron, antioxidant defense, and mitochondrial function. Pharmacological inhibitors of the iron-dependent enzyme class prolyl hydroxylases (PHD), which target alpha subunits of HIF proteins for degradation, have recently been demonstrated to alleviate neurodegeneration associated with stroke and hypoxic-ischemic injuries. Here we report that inhibition of PHD by 3,4-dihydroxybenzoate (DHB) protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigral dopaminergic cell loss and up-regulates HIF-1alpha within these neurons. Elevations in mRNA and protein levels of HIF-dependent genes heme oxygenase-1 (Ho-1) and manganese superoxide dismutase (Mnsod) following DHB pretreatment alone are also maintained in the presence of MPTP. MPTP-induced reductions in ferroportin and elevations in nigral and striatal iron levels were reverted to levels comparable with that of untreated controls with DHB pretreatment. Reductions in pyruvate dehydrogenase mRNA and activity resulting from MPTP were also found to be attenuated by DHB. In vitro, the HIF pathway was activated in N27 cells grown at 3% oxygen treated with either PHD inhibitors or an iron chelator. Concordant with our in vivo data, the MPP(+)-elicited increase in total iron as well as decreases in cell viability were attenuated in the presence of DHB. Taken together, these data suggest that protection against MPTP neurotoxicity may be mediated by alterations in iron homeostasis and defense against oxidative stress and mitochondrial dysfunction brought about by cellular HIF-1alpha induction. This study provides novel data extending the possible therapeutic utility of HIF induction to a Parkinson disease model of neurodegeneration, which may prove beneficial not only in this disorder itself but also in other diseases associated with metal-induced oxidative stress.
authors.affiliation: Buck Institute for Age Research, Novato, California 94945, USA.
authors.forename: Donna W
authors.initials: DW
authors.lastname: Lee
authors.forename: Subramanian
authors.initials: S
authors.lastname: Rajagopalan
authors.forename: Ambreena
authors.initials: A
authors.lastname: Siddiq
authors.forename: Roberto
authors.initials: R
authors.lastname: Gwiazda
authors.forename: Lichuan
authors.initials: L
authors.lastname: Yang
authors.forename: M Flint
authors.initials: MF
authors.lastname: Beal
authors.forename: Rajiv R
authors.initials: RR
authors.lastname: Ratan
authors.forename: Julie K
authors.initials: JK
authors.lastname: Andersen
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000737:chemistry*; D000818:Animals; D005786:Gene Expression Regulation; D051547:Heme Oxygenase-1 / Q000737:chemistry; D062385:Hydroxybenzoates / Q000494:pharmacology; D051793:Hypoxia-Inducible Factor 1 / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000378:metabolism; D010100:Oxygen / Q000737:chemistry; D010300:Parkinson Disease / Q000188:drug therapy* / Q000473:pathology; D011393:Procollagen-Proline Dioxygenase / Q000037:antagonists & inhibitors*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats
chemical_list: C520290:3,4-dihydroxybenzoate; D062385:Hydroxybenzoates; D051793:Hypoxia-Inducible Factor 1; D012333:RNA, Messenger; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D011393:Procollagen-Proline Dioxygenase; D051547:Heme Oxygenase-1; D010100:Oxygen
references.citation: Brain. 1991 Aug;114 ( Pt 4):1953-75
references.pmid: 1832073
references.citation: J Neurosci. 2007 Jan 10;27(2):304-7
references.pmid: 17215390
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2301-6
references.pmid: 17284606
references.citation: J Neurochem. 1989 Jun;52(6):1830-6
references.pmid: 2723638
references.citation: J Biol Chem. 2004 Mar 5;279(10):9504-11
references.pmid: 14681229
references.citation: Genes Dev. 1998 Nov 1;12(21):3320-4
references.pmid: 9808618
references.citation: Cell Metab. 2006 Mar;3(3):187-97
references.pmid: 16517406
references.citation: Adv Exp Med Biol. 2003;530:611-7
references.pmid: 14562758
references.citation: Stroke. 2004 Nov;35(11 Suppl 1):2687-9
references.pmid: 15472113
references.citation: Nat Protoc. 2006;1(4):2088-90
references.pmid: 17487199
references.citation: J Neurochem. 1997 Jan;68(1):328-32
references.pmid: 8978742
references.citation: J Neurol Sci. 1992 Mar;108(1):80-7
references.pmid: 1385624
references.citation: J Biol Chem. 1986 Jun 15;261(17):7819-23
references.pmid: 3011801
references.citation: Blood. 2005 Jun 15;105(12):4861-4
references.pmid: 15713792
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30
references.pmid: 9380736
references.citation: Toxicol Appl Pharmacol. 1992 Sep;116(1):85-91
references.pmid: 1326794
references.citation: Brain Res. 1998 Oct 26;809(1):58-67
references.pmid: 9795136
references.citation: Blood. 2006 Aug 15;108(4):1402-5
references.pmid: 16574947
references.citation: J Neurol Sci. 1995 Dec;134 Suppl:33-44
references.pmid: 8847543
references.citation: Neurology. 2008 Apr 15;70(16 Pt 2):1411-7
references.pmid: 18172063
references.citation: Blood. 1998 Oct 1;92(7):2260-8
references.pmid: 9746763
references.citation: Nat Genet. 2003 Dec;35(4):331-40
references.pmid: 14608355
references.citation: J Biol Chem. 2003 Aug 15;278(33):30772-80
references.pmid: 12788921
references.citation: Trends Mol Med. 2004 Jan;10(1):1-3
references.pmid: 14720577
references.citation: Ann N Y Acad Sci. 2004 Mar;1012:306-25
references.pmid: 15105275
references.citation: Semin Pediatr Neurol. 2006 Sep;13(3):142-8
references.pmid: 17101452
references.citation: Neurobiol Dis. 1998 Oct;5(4):253-8
references.pmid: 9848095
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10393-8
references.pmid: 8816811
references.citation: Neurosci Lett. 2005 May 6;379(2):96-100
references.pmid: 15823423
references.citation: J Neurochem. 1990 Oct;55(4):1327-39
references.pmid: 2144582
references.citation: Free Radic Biol Med. 2003 Sep 1;35(5):540-7
references.pmid: 12927603
references.citation: Brain Res. 2005 Aug 16;1053(1-2):10-8
references.pmid: 16045899
references.citation: Biochem Pharmacol. 1995 Jun 16;49(12):1821-6
references.pmid: 7598744
references.citation: J Biol Chem. 2005 Dec 16;280(50):41732-43
references.pmid: 16227210
references.citation: J Biol Chem. 2000 Sep 22;275(38):29643-7
references.pmid: 10882714
references.citation: J Neurosci. 2008 Feb 20;28(8):1988-93
references.pmid: 18287515
references.citation: Brain Res. 2004 Mar 19;1001(1-2):108-17
references.pmid: 14972659
references.citation: Nat Cell Biol. 1999 Jul;1(3):152-7
references.pmid: 10559901
references.citation: J Neurochem. 2008 Jun 1;105(6):2466-76
references.pmid: 18331585
references.citation: Mol Pharmacol. 1978 Jul;14(4):644-53
references.pmid: 567274
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18578-83
references.pmid: 19011085
references.citation: Biochem Soc Trans. 2003 Dec;31(Pt 6):1143-51
references.pmid: 14641014
references.citation: FASEB J. 2004 Sep;18(12):1462-4
references.pmid: 15240563
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2006;26(6):670-3
references.pmid: 17357485
references.citation: Stroke. 1995 Apr;26(4):688-94; discussion 694-5
references.pmid: 7709418
references.citation: Nature. 2005 Dec 15;438(7070):954-9
references.pmid: 16355213
references.citation: Cell. 2006 Oct 20;127(2):397-408
references.pmid: 17055439
references.citation: Neurobiol Aging. 2009 Sep;30(9):1466-76
references.pmid: 18191877
references.citation: Neurology. 1989 Nov;39(11):1483-7
references.pmid: 2812327
references.citation: Exp Cell Res. 2005 May 15;306(1):274-84
references.pmid: 15878351
references.citation: Neuroscience. 2004;128(3):487-96
references.pmid: 15381278
references.citation: Neuron. 2003 Mar 27;37(6):899-909
references.pmid: 12670420
references.citation: Neurobiol Dis. 2003 Dec;14(3):524-34
references.pmid: 14678768
references.citation: Gene Expr. 1997;6(5):287-99
references.pmid: 9368100
references.citation: Proc Natl Acad Sci U S A. 1997 May 13;94(10):4890-4
references.pmid: 9144160
references.citation: Cell Metab. 2006 Mar;3(3):177-85
references.pmid: 16517405
references.citation: J Neurosci. 2007 Jun 6;27(23):6320-32
references.pmid: 17554006
references.citation: Neurochem Int. 2008 May;52(6):1044-51
references.pmid: 18082289
references.citation: J Neurol Sci. 1991 Feb;101(2):198-203
references.pmid: 1903438
references.citation: Neurochem Int. 2009 Jan;54(1):43-8
references.pmid: 19000728
references.citation: Kidney Int. 1995 Oct;48(4):1298-307
references.pmid: 8569092
references.citation: Blood. 1993 Dec 15;82(12):3610-5
references.pmid: 8260699
references.citation: Eur J Neurosci. 2004 Mar;19(6):1494-504
references.pmid: 15066146
references.citation: J Neural Transm (Vienna). 1997;104(4-5):469-81
references.pmid: 9295179
references.citation: J Biol Chem. 2008 Apr 25;283(17):11435-44
references.pmid: 18305118
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9493-8
references.pmid: 8790358
references.citation: Am J Pathol. 2000 Aug;157(2):411-21
references.pmid: 10934146